About Us

Crucial Innovations Corp (CINV) is pioneering the future of medicinal cannabis. As a licensed organic medicine company, we are committed to cultivating premium cannabis genetics and psilocybin to create effective, affordable treatment options for patients worldwide.

From seed to sale, we oversee the entire process to ensure the highest quality and consistency.

From seed to sale, we oversee the entire process to ensure the highest quality and consistency.

Leveraging award-winning techniques perfected in the US recreational market.

Leveraging award-winning techniques perfected in the US recreational market.

We aim to develop safe, effective psilocybin therapies that transform patient wellbeing.

We aim to develop safe, effective psilocybin therapies that transform patient wellbeing.

We empower patients and doctors with plant-based treatment options that improve quality of life.

We empower patients and doctors with plant-based treatment options that improve quality of life.

Our Vertically Integrated Approach

From seed to sale, we oversee the entire process to ensure the highest quality and consistency. Our subsidiaries conduct R&D, cultivation, and processing at our state-of-the-art solar-powered facilities in South Africa. We then facilitate distribution and sale through trusted European partners, providing patients access to rigorously tested medical cannabis.

Unparalleled Medical Cannabis

Leveraging award-winning techniques perfected in the US recreational market, our team creates exclusive strains with exceptional therapeutic properties. We go beyond isolated compounds to retain the full spectrum of synergistic cannabinoids, terpenes, and flavonoids essential for personalized care.

Medicinal Psilocybin Innovation

As research reveals psilocybin’s promise for mental health, we are applying to pioneer its compassionate, regulated use through our R&D license. We aim to develop safe, effective psilocybin therapies that transform patient wellbeing.

Our Mission

We empower patients and doctors with plant-based treatment options that improve quality of life. By pioneering cannabis and psilocybin cultivation, we create accessible alternatives to patented pharmaceuticals.

Meet our team

Contact us today to learn more about our life-changing medicinal cannabis products and patient-centered services.

JP Doran

CEO, CINV

Timothy Ambrose

Chairman, CINV

Darlington Mazvidza

CFO, CINV

Bernard Pieters

COO, Ember Pharms

Chris Ioannou

Head of Cultivation, CINV

Kyle Snoxell

Business Development Manager, Ember Pharms

Our cultivation techniques produce premium cannabis flower with exceptional structure, yields, THC levels, and terpene profiles.

Chris Ioannou,

Head of Cultivation

Through our exceptional genetics and strategic alliances, we are poised to supply the pharmaceutical industry with unparalleled GMP- Flower and GMP-Oil.

Jon-Paul Doran,

Founder & CEO